Paola Lanza

1.7k total citations
54 papers, 1.4k citations indexed

About

Paola Lanza is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Paola Lanza has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Molecular Biology and 10 papers in Virology. Recurrent topics in Paola Lanza's work include HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Paola Lanza is often cited by papers focused on HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Paola Lanza collaborates with scholars based in Italy, United States and Canada. Paola Lanza's co-authors include Franco O. Ranelletti, Paola Palozza, Rosario Billetta, Gabriella Calviello, Nicola Maggiano, Luigi Maria Larocca, Riccardo Ricci, Gianna Maria Bartoli, Salvatore Albani and Berent J. Prakken and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Paola Lanza

52 papers receiving 1.3k citations

Peers

Countries citing papers authored by Paola Lanza

Since Specialization

Citations

This map shows the geographic impact of Paola Lanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola Lanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola Lanza more than expected).

Fields of papers citing papers by Paola Lanza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paola Lanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola Lanza. The network helps show where Paola Lanza may publish in the future.

Co-authorship network of co-authors of Paola Lanza

This figure shows the co-authorship network connecting the top 25 collaborators of Paola Lanza. A scholar is included among the top collaborators of Paola Lanza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paola Lanza. Paola Lanza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit 2024 ·Infection ·(unknown), Liana Signorini, Silvia Lorenzotti, Paola Lanza, (unknown), (unknown), (unknown), Simone Piva, Matteo Rota, (unknown), Frank Rasulo, Matteo Filippini, (unknown), (unknown), Alberto Matteelli	0
2	Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review 2023 ·Vascular Health and Risk Management ·José López-López, (unknown), Paola Lanza, Patricio López‐Jaramillo	6
3	Waist circumference cut-off points to identify major cardiovascular events and incident diabetes in Latin America: findings from the prospective Urban rural epidemiology study Colombia 2023 ·Frontiers in Cardiovascular Medicine ·José López-López, (unknown), Paola Lanza, Daniel Martínez-Bello, Diego Gómez-Arbeláez, Johanna Otero, Daniel D. Cohen, Maritza Pérez-Mayorga, (unknown), Sumathy Rangarajan, Salim Yusuf, Patricio López‐Jaramillo	4
4	Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 2021 ·JAC-Antimicrobial Resistance ·Marianna Meschiari, Sara Volpi, Matteo Faltoni, Giovanni Dolci, Gabriella Orlando, Erica Franceschini, Marianna Menozzi, Mario Sarti, (unknown), (unknown), (unknown), Paola Lanza, Silvia Lorenzotti, (unknown), Liana Signorini, (unknown), Milo Gatti, Federico Pea, Francesco Castelli, Cristina Mussini	43
5	Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study 2021 ·PLoS ONE ·Antonio Mancini, Francesco Guidi, Carmine Bruno, Flavia Angelini, Edoardo Vergani, Paola Lanza, Alvaro Mordente, Elisabetta Meucci, Andrea Silvestrini	4
6	Furuncular myiasis in Italian traveler returning from Kenya 2020 ·The Journal of Infection in Developing Countries ·(unknown), (unknown), (unknown), Paola Lanza, Claudio Farina	6
7	RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 2018 ·In Vivo ·Ernesto Rossi, Cinzia Bagalá, Frediano Inzani, Emanuele Leoncini, Chiara Brunelli, Paola Lanza, Michele A. Basso, Gian Carlo Mattiucci, Alessandra Cassano, Guido Rindi, Carlo Barone, Giovanni Schinzari	8
8	Litiasi biliare e renale in paziente con coinfezione HIV e HCV genotipo 4 in corso di terapia con daclatasvir/sofosbuvir + ribavirina e atazanavir/ritonavir + abacavir/lamivudina: caso clinico 2017 ·Recenti Progressi in Medicina ·Andrea Vavassori, Paola Lanza, Ilaria Izzo, Salvatore Casari, Silvia Odolini, S. Zaltron, Elena K. Festa, Francesco Castelli	0
9	Antioxidant and Anti-Inflammatory Effects of Selected Natural Compounds Contained in a Dietary Supplement on Two Human Immortalized Keratinocyte Lines 2014 ·BioMed Research International ·Elena Fasano, Simona Serini, (unknown), Sonia Trombino, Leonardo Celleno, Paola Lanza, Achille Cittadini, Gabriella Calviello	39
10	Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis 2012 ·Clinical Immunology ·Rosario Billetta, (unknown), (unknown), (unknown), Huib de Jong, Carol Meschter, Paola Lanza, Salvatore Albani	13
11	The sensitivity to -carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells 2008 ·Carcinogenesis ·Paola Palozza, Rosanna Sestito, Nevio Picci, Paola Lanza, G. Monego, Franco O. Ranelletti	30
12	Human parathyroid hormone-related protein and human parathyroid hormone receptor type 1 are expressed in human medulloblastomas and regulate cell proliferation and apoptosis in medulloblastoma-derived cell lines 2007 ·Acta Neuropathologica ·Marco Gessi, Giovanni Monego, Gabriella Calviello, Paola Lanza, Felice Giangaspero, Andrea Silvestrini, Libero Lauriola, Franco O. Ranelletti	14
13	Clustering of T Cell Ligands on Artificial APC Membranes Influences T Cell Activation and Protein Kinase C θ Translocation to the T Cell Plasma Membrane 2005 ·The Journal of Immunology ·Francesca Giannoni, Joellen Barnett, Kun Bi, (unknown), Paola Lanza, Patrizia Marchese, Rosario Billetta, Randi Vita, (unknown), Berent J. Prakken, William W. Kwok, Eli E. Sercarz, Amnon Altman, Salvatore Albani	62
14	Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis 2004 ·Proceedings of the National Academy of Sciences ·Berent J. Prakken, (unknown), Tho Le, Francesca Giannoni, Gisella Puga Yung, John F. Scavulli, Diane Amox, Sarah Roord, Ismé de Kleer, (unknown), Paola Lanza, Charles C. Berry, Margherita Massa, Rosario Billetta, Salvatore Albani	175
15	Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination 1998 ·Vaccine ·Paola Lanza, Ronald B. Moss, Wieslawa Giermakowska, (unknown), Steven P. Richieri, (unknown), Fred C. Jensen, (unknown), Dennis J. Carlo	4
16	Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, Remune™) in Human Immunodeficiency Virus Type-1 Seropositive Subjects 1997 ·Viral Immunology ·Ronald B. Moss, Wieslawa Giermakowska, Paola Lanza, John L. Turner, Mark R. Wallace, Fred C. Jensen, Georgia Theofan, Steven P. Richieri, Dennis J. Carlo	24
17	Anti-HIV Type 1 Properties of Chemically Modified Heparins with Diminished Anticoagulant Activity 1994 ·AIDS Research and Human Retroviruses ·Lucia Lopalco, (unknown), Paola Lanza, G Zoppetti, (unknown), Flavio Leoni, Alberto Beretta, Antonio G. Siccardi	19
18	A Method to Analyze the Interaction Between gp120 of Human Immunodeficiency Virus and CD4 1992 ·Viral Immunology ·Paola Lanza, Laura Washington, Maurizio Zanetti	2
19	Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. 1991 ·The Journal of Experimental Medicine ·Fabio Grassi, Raffaella Meneveri, Martin Gullberg, Lucia Lopalco, (unknown), Paola Lanza, C. De Santis, Göran Brattsand, Stefano Buttò, Enrico Ginelli	94
20	Chemical residues of ganglioside molecules involved in interactions with lymphocyte surface targets leading to CD4 masking and inhibition of mitogenic proliferation 1990 ·European Journal of Immunology ·Fabio Grassi, Lucia Lopalco, Paola Lanza, (unknown), (unknown), Alessandro Di Martino, G. Kirschner, L. Callegaro, Luigi Chieco‐Bianchi, Antonio G. Siccardi	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact